Author Correction: A new tau dephosphorylation-targeting chimera for the treatment of tauopathies

Correction to: Acta Pharmacologica Sinica (2024) 0:1-10; https://doi.org/10.1038/s41401-024-01326-4, published online 02 July 2024

The authors would like to apologize for the errors in the previously published images of Fig. 2f. These inaccuracies were due to an oversight during the preparation of the figures. The authors have carefully checked the raw data and corrected these accidentally confused figures.

The corrected versions of the affected figures are now presented. It is important to note that these corrections do not alter the findings or conclusions of the paper. The overall interpretation and impact of the study remain unchanged.

The authors sincerely apologize for any inconvenience caused to the journal and its readers. They are grateful for the understanding and support of the editorial team and the readers in rectifying these errors.

Correct Figure 2f

Fig. 2.: D14 simultaneously interacts with tau and PP2A.

f D14 reduced p-tau in a time and dose-dependent way. Significant tau-dephosphorylating efficiency was observed 24 h following administration, and at concentrations among 5–100 μM.